» Articles » PMID: 12605725

The Production of Antibody Fragments and Antibody Fusion Proteins by Yeasts and Filamentous Fungi

Overview
Publisher Biomed Central
Date 2003 Feb 28
PMID 12605725
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

In this review we will focus on the current status and views concerning the production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. We will focus on single-chain antibody fragment production (scFv and VHH) by these lower eukaryotes and the possible applications of these proteins. Also the coupling of fragments to relevant enzymes or other components will be discussed. As an example of the fusion protein strategy, the 'magic bullet' approach for industrial applications, will be highlighted.

Citing Articles

Harnessing the potential of microalgae for the production of monoclonal antibodies and other recombinant proteins.

Rajput B, Ikram S, Tripathi B Protoplasma. 2024; 261(6):1105-1125.

PMID: 38970700 DOI: 10.1007/s00709-024-01967-6.


A fast, ultrasensitive SERS immunoassay to detect SARS-CoV-2 in saliva.

Mohammadi M, Antoine D, Vitt M, Dickie J, Sultana Jyoti S, Wall J Anal Chim Acta. 2022; 1229:340290.

PMID: 36156215 PMC: 9395977. DOI: 10.1016/j.aca.2022.340290.


Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective.

Risser F, Urosev I, Lopez-Morales J, Sun Y, Nash M Biophys Rev. 2022; 14(2):427-461.

PMID: 35399372 PMC: 8984085. DOI: 10.1007/s12551-022-00950-w.


A comprehensive comparison between camelid nanobodies and single chain variable fragments.

Asaadi Y, Jouneghani F, Janani S, Rahbarizadeh F Biomark Res. 2021; 9(1):87.

PMID: 34863296 PMC: 8642758. DOI: 10.1186/s40364-021-00332-6.


Designing and generating a single-chain fragment variable (scFv) antibody against IL2Rα (CD25): An and study.

Navabi P, Ganjalikhany M, Jafari S, Dehbashi M, Ganjalikhani-Hakemi M Iran J Basic Med Sci. 2021; 24(3):360-368.

PMID: 33995947 PMC: 8087844. DOI: 10.22038/ijbms.2021.51709.11728.


References
1.
Ward M, Wilson L, Kodama K, Rey M, Berka R . Improved production of chymosin in Aspergillus by expression as a glucoamylase-chymosin fusion. Biotechnology (N Y). 1990; 8(5):435-40. DOI: 10.1038/nbt0590-435. View

2.
Glockshuber R, Malia M, Pfitzinger I, Pluckthun A . A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry. 1990; 29(6):1362-7. DOI: 10.1021/bi00458a002. View

3.
Pollock D, Kutzko J, Williams J, Echelard Y, Meade H . Transgenic milk as a method for the production of recombinant antibodies. J Immunol Methods. 2000; 231(1-2):147-57. PMC: 7125573. DOI: 10.1016/s0022-1759(99)00151-9. View

4.
Yokota T, Milenic D, Whitlow M, Schlom J . Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 1992; 52(12):3402-8. View

5.
Brinkmann U, Reiter Y, Jung S, Lee B, Pastan I . A recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Proc Natl Acad Sci U S A. 1993; 90(16):7538-42. PMC: 47177. DOI: 10.1073/pnas.90.16.7538. View